Table 2b.
Frequency of initial symptoms (2 weeks pre‐/post‐testing) by recovery status in the HOPE registry
| Fully recovered (n = 103), n (%) | Symptomatic, functional (n = 58), n (%) | Symptomatic, limited (n = 18), n (%) | Χ 2, p value | |
|---|---|---|---|---|
| Respiratory | ||||
| Sore throat | 29 (28) | 24 (41) | 11 (61) | 0.03 |
| Runny nose | 18 (17) | 17 (29) | 2 (11) | 0.21 |
| Shortness of breath | 25 (24) | 21 (36) | 14 (78) | <0.0001 |
| Pressure in chest/tightness | 17 (38) | 14 (31) | 14 (31) | <0.0001 |
| Persistent cough | 51 (50) | 38 (65) | 14 (78) | 0.04 |
| Systemic | ||||
| Any fever | 82 (52) | 43 (31) | 13 (72) | 0.47 |
| Headache | 51 (50) | 43 (74) | 11 (61) | 0.01 |
| Joint aches | 16 (15) | 19 (33) | 8 (44) | 0.004 |
| Muscle aches | 49 (48) | 36 (62) | 13 (72) | 0.09 |
| Lack of energy | 75 (73) | 51 (88) | 17 (94) | 0.04 |
| Chills | 37 (36) | 25 (43) | 8 (44) | 0.46 |
| Gastrointestinal | ||||
| Loss of appetite | 21 (39) | 21 (39) | 10 (19) | 0.003 |
| Nausea/vomiting | 15 (15) | 16 (28) | 4 (22) | 0.23 |
| Diarrhea | 17 (17) | 14 (24) | 7 (39) | 0.15 |
| Neurologic | ||||
| Dizziness | 4 (4) | 10 (17) | 4 (22) | <0.0001 |
| Hallucinations | 1 (1) | 5 (9) | 2 (11) | 0.06 |
| Loss of smell | 45 (44) | 40 (69) | 15 (83) | 0.001 |
| Loss of taste | 38 (37) | 38 (65) | 12 (67) | 0.001 |